Non-Alcoholic Steatohepatitis (NASH) Trial

Non-Alcoholic Steatohepatitis (NASH) Trial 

Digestive Disease Associates of Rockland and Gen1 Research have partnered in a study evaluating an investigational drug for treatment of liver fibrosis in adult patients who have non-alcoholic steatohepatitis (NASH).  To qualify, participants must:


  • Be between the ages if 18 and 75
  • Have had liver biopsy or be willing to undergo a liver biopsy

 Qualified participants may receive:


  • Compensation for time & travel
  • Study-related care at no cost

 For more information, please contact our Clinical Research Coordinator, Samantha Oberdier, at (845) 367-1621 or




The following is reprinted from the CCFA March 11, 2020 email blast to their provider network. 

We understand that there’s a lot of information in the news about the...

Latest News


Dear Patients

Your Digestive Disease Associates of Rockland Physicians and Nurse Practitioners are here to serve you and can now provide care via telehealth from the comfort and safety of...